Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO World Congress on Gastrointestinal Cancer 2021, 30 June - 3 July

23 Jun 2021
Basic Science;  Cancer in Special Situations/ Populations;  Cancer Prevention;  Rare Cancers;  Supportive and Palliative Care;  Therapy
Gastrointestinal Cancers

LUGANO, Switzerland - The 2021 World Congress on Gastrointestinal Cancer will be held as a virtual meeting, on 30 June – 3 July.


  • Gender and race: new concepts in clinical trials
  • Colorectal cancer screening and the future of chemoprevention
  • Novel immuno-oncology mechanisms and approaches in GI cancers
  • Rare GI cancers: updates and new clinical data
  • New developments in radiation oncology
  • The effetcts of drug interactions in GI oncology
  • How to improve outcomes of patients with metastatic pancreatic cancer

The programme will address other topics such as advances in surgery and transplant, new diagnostic and screening techniques, new agents and treatment strategies, biomarkers for checkpoint inhibitors. 

The results of more than 300 studies from researchers in various parts of the world will be presented either as oral or poster presentations, and published online as a supplement of Annals of Oncology. The abstract titles can be viewed through the online programme.

Press Programme

  • Bowel cancer data reinforce need to reduce unnecessary antibiotic use
    Doctors and patients are being advised to reduce unnecessary antibiotic use following new data suggesting that these medicines may increase the risk of cancer of the large intestine (colon), especially in people under 50 years.
  • “Poorer survival in obese colorectal cancer patients possibly linked to lower chemotherapy doses”
    Obese patients with colorectal cancer receive lower cumulative relative doses of adjuvant chemotherapy than non-obese patients. Further findings showed that cumulative relative chemotherapy dose was associated with survival so may explain the poorer survival that has been seen in obese patients receiving adjuvant chemotherapy for colorectal cancer.

Media registration

The WGI Congress welcomes media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process with the media registration form, accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), virtual exhibition and industry satellite symposia, Congress webcasts, and embargoed material.  

For further information

WGI Press Office

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.